PATRIZI, Ornella
 Distribuzione geografica
Continente #
NA - Nord America 1.179
EU - Europa 687
AS - Asia 613
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
AF - Africa 2
SA - Sud America 1
Totale 2.490
Nazione #
US - Stati Uniti d'America 1.176
CN - Cina 539
PL - Polonia 293
IT - Italia 122
UA - Ucraina 107
FR - Francia 49
DE - Germania 34
HK - Hong Kong 33
GB - Regno Unito 25
IE - Irlanda 20
SG - Singapore 20
FI - Finlandia 19
IN - India 9
VN - Vietnam 8
SE - Svezia 7
EU - Europa 5
NL - Olanda 5
BE - Belgio 4
AU - Australia 3
CA - Canada 3
CZ - Repubblica Ceca 2
JP - Giappone 2
MU - Mauritius 2
AR - Argentina 1
IR - Iran 1
TR - Turchia 1
Totale 2.490
Città #
Shenzhen 403
Warsaw 293
Fairfield 193
Houston 116
Woodbridge 106
Brescia 100
Ashburn 92
Cambridge 87
Jacksonville 77
Seattle 75
Wilmington 73
Chandler 68
New York 42
Ann Arbor 39
Princeton 36
Hong Kong 33
Beijing 32
Dearborn 27
Nanjing 25
Dublin 20
Nanchang 11
Helsinki 10
Shenyang 10
Dong Ket 8
Jinan 8
Lancaster 7
Singapore 7
Changsha 6
Des Moines 6
London 6
San Diego 6
Taizhou 6
Tianjin 6
Jiaxing 4
San Francisco 4
Shanghai 4
Zhengzhou 4
Hebei 3
Kilburn 3
Phoenix 3
Toronto 3
Brussels 2
Charlotte 2
Hangzhou 2
Leawood 2
Los Angeles 2
Milan 2
Orange 2
San Benedetto Po 2
Sydney 2
Waanrode 2
Washington 2
Ardabil 1
Baotou 1
Boardman 1
Brno 1
Brooklyn 1
Canberra 1
Changchun 1
Chicago 1
Chiswick 1
Frankfurt am Main 1
Fremont 1
Glendale 1
Gravedona 1
Haikou 1
Lappeenranta 1
Las Vegas 1
Ningbo 1
Olomouc 1
Palermiti 1
Poncarale 1
Redmond 1
Rezzato 1
Salerno 1
San Mateo 1
Santa Clara 1
Tokyo 1
Verona 1
Vobarno 1
Wenzhou 1
Xian 1
Totale 2.114
Nome #
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects. 514
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations 282
NFKB1 regulates human NK cell maturation and effector functions 274
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 151
The RAC2-PI3K axis regulates human NK cell maturation and function 151
Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease 139
CTLA-4 regulates human Natural Killer cell effector functions 131
Inherited DOCK2 deficiency in patients with early-onset invasive infections 123
Effects of opioid therapy on human natural killer cells. 118
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis 109
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 106
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer. 99
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies 79
Response to the Letter to the Editor Regarding “Functional evaluation of natural killer cell cytotoxic activity in NFKB-2 mutated patients” 69
P85α is an intrinsic regulator of human natural killer cell effector functions 67
Screening genetico per determinare la frequenza di grosse delezioni nei geni SDHx e VHL in una coorte italiana di pazienti affetti da Feocromocitoma/Paraganglioma. 66
Natural killer cell impairment in ovarian clear cell carcinoma 45
Lack of DOCK8 impairs the primary biologic functions of human NK cells and abrogates CCR7 surface expression in a WASP-independent manner 32
Totale 2.555
Categoria #
all - tutte 8.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020431 0 0 0 48 39 67 58 61 45 64 23 26
2020/2021452 10 31 7 142 23 35 12 35 49 44 47 17
2021/2022229 27 30 5 13 1 6 10 13 8 31 15 70
2022/2023212 50 0 2 14 17 49 1 24 28 1 11 15
2023/2024582 19 6 419 5 8 53 8 8 34 2 0 20
2024/20252 1 1 0 0 0 0 0 0 0 0 0 0
Totale 2.555